Literature DB >> 15008217

[Lipoid nephrosis in childhood].

Patrick Niaudet1.   

Abstract

Lipoid nephrosis or idiopathic nephrotic syndrome, the most frequent glomerular disease in childhood, is defined by the association of a nephrotic syndrome and minimal changes on renal biopsy or unspecific lesions such as focal and segmental glomerular sclerosis or diffuse mesangial proliferation. Several complications related to the nephrotic syndrome may occur: infections particularly bacterial infections, thrombo-embolic accidents, hypovolemia with shock. Other complications are secondary to the treatment: steroid therapy, immunosuppressants. The outcome is related to the response to steroid therapy. In case of steroid responsiveness, the risk is the relapse when the steroid dosage is tapered or stopped and the complications related to the treatment which is given to maintain remission. In case of steroid resistance, the risk is that of progression to renal failure which occurs in approximately 50% of patients after 5 years. Moreover, the nephrotic syndrome may recur after renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15008217

Source DB:  PubMed          Journal:  Rev Prat        ISSN: 0035-2640


  3 in total

1.  Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study.

Authors:  Djalila Mekahli; Aurelia Liutkus; Bruno Ranchin; Anchalee Yu; Lucie Bessenay; Eric Girardin; Rita Van Damme-Lombaerts; Jean-Bernard Palcoux; François Cachat; Marie-Pierre Lavocat; Guylhène Bourdat-Michel; François Nobili; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

2.  Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: A single centre study.

Authors:  Elham Ibrahim Seif; Eman Abdel-Salam Ibrahim; Nadia Galal Elhefnawy; Manal Ibrahim Salman
Journal:  J Nephropathol       Date:  2013-01-01

3.  Recurrent focal segmental glomerulosclerosis: a discrete clinical entity.

Authors:  Elena Torban; Martin Bitzan; Paul Goodyer
Journal:  Int J Nephrol       Date:  2012-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.